Frontlight ResearchEarly access
CompletedNo phase
Effectiveness and Safety of Corneal Collagen Cross Linking After Induction of Stromal Emphysema in Keratoconus
Key facts
- Who runs it
- Cairo University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 39 people enrolled
- Started
- 1 Oct 2022
- Ended
- 1 Oct 2024
- Type of study
- Interventional
- Treatments tested
- Corneal collagen cross-linking with induction of corneal stromal emphysema
- Record updated
- 23 February 2026
Who can take part
- Age
- 17 years to 33 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Progressive KC proven by clinical examination, tomography, and pachymetry
- Thinnest corneal location thickness between 390 to 450 microns
Who cannot take part
- Previous ocular Trauma or Surgery
- Collagen vascular disease, autoimmune disease and patients receiving immunosuppressive therapy
- History of herpetic eye disease
- Ocular surface disease and dry eye disease
- Nystagmus or other conditions that interfere with patient's fixation
- Diabetes mellitus
- Central corneal scarring
- Cornea guttata
- Vernal and atopic keratoconjunctivitis
- Cataract
- Glaucoma, intraocular pressure less than 10 or more than 21 mmHg
- Posterior segment abnormalities
- pregnancy
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
in this study we evaluated the effectiveness and safety of corneal collagen cross-linking in keratoconic eyes with thin cornea after induction of stromal emphysema prior to riboflavin instillation and UV-A corneal irradiation
The group in the trial
- Patients with progressive keratoconusOther group
Treatment: Corneal collagen cross-linking with induction of corneal stromal emphysema
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 23 February 2026